GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lexagene Holdings Inc (OTCPK:LXXGQ) » Definitions » Cyclically Adjusted PB Ratio

Lexagene Holdings (Lexagene Holdings) Cyclically Adjusted PB Ratio : 8.06 (As of Jun. 04, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Lexagene Holdings Cyclically Adjusted PB Ratio?

As of today (2024-06-04), Lexagene Holdings's current share price is $0.0806. Lexagene Holdings's Cyclically Adjusted Book per Share for the quarter that ended in Nov. 2022 was $0.01. Lexagene Holdings's Cyclically Adjusted PB Ratio for today is 8.06.

The historical rank and industry rank for Lexagene Holdings's Cyclically Adjusted PB Ratio or its related term are showing as below:

LXXGQ's Cyclically Adjusted PB Ratio is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.095
* Ranked among companies with meaningful Cyclically Adjusted PB Ratio only.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Lexagene Holdings's adjusted book value per share data for the three months ended in Nov. 2022 was $0.009. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.01 for the trailing ten years ended in Nov. 2022.

Shiller PE for Stocks: The True Measure of Stock Valuation


Lexagene Holdings Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Lexagene Holdings's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lexagene Holdings Cyclically Adjusted PB Ratio Chart

Lexagene Holdings Annual Data
Trend Mar13 Mar14 Mar15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.99 1.46 3.23 7.74 6.97

Lexagene Holdings Quarterly Data
Feb18 May18 Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.86 6.97 6.50 9.11 15.29

Competitive Comparison of Lexagene Holdings's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, Lexagene Holdings's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lexagene Holdings's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lexagene Holdings's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Lexagene Holdings's Cyclically Adjusted PB Ratio falls into.



Lexagene Holdings Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Lexagene Holdings's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.0806/0.01
=8.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lexagene Holdings's Cyclically Adjusted Book per Share for the quarter that ended in Nov. 2022 is calculated as:

For example, Lexagene Holdings's adjusted Book Value per Share data for the three months ended in Nov. 2022 was:

Adj_Book=Book Value per Share/CPI of Nov. 2022 (Change)*Current CPI (Nov. 2022)
=0.009/125.6074*125.6074
=0.009

Current CPI (Nov. 2022) = 125.6074.

Lexagene Holdings Quarterly Data

Book Value per Share CPI Adj_Book
201212 -0.057 96.871 -0.074
201303 -0.110 98.209 -0.141
201306 -0.157 98.518 -0.200
201309 -0.128 98.790 -0.163
201312 -0.102 98.326 -0.130
201403 -0.169 99.695 -0.213
201406 0.035 100.560 0.044
201409 0.011 100.428 0.014
201412 0.008 99.070 0.010
201503 0.003 99.621 0.004
201506 0.010 100.684 0.012
201509 0.007 100.392 0.009
201512 0.003 99.792 0.004
201603 -0.006 100.470 -0.008
201606 -0.009 101.688 -0.011
201609 0.010 101.861 0.012
201702 0.022 102.779 0.027
201705 0.033 103.256 0.040
201708 0.026 103.587 0.032
201711 0.014 104.072 0.017
201802 0.059 105.052 0.071
201805 0.036 106.148 0.043
201808 0.070 106.383 0.083
201811 0.039 106.338 0.046
201902 0.021 106.649 0.025
201905 0.025 108.048 0.029
201908 0.014 108.245 0.016
201911 0.043 108.519 0.050
202002 0.043 109.139 0.049
202005 0.027 108.175 0.031
202008 0.036 109.662 0.041
202011 0.091 109.793 0.104
202102 0.092 110.968 0.104
202105 0.071 113.576 0.079
202108 0.052 115.421 0.057
202111 0.031 117.269 0.033
202202 0.046 119.703 0.048
202205 0.032 123.323 0.033
202208 0.018 124.958 0.018
202211 0.009 125.607 0.009

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Lexagene Holdings  (OTCPK:LXXGQ) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Lexagene Holdings Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Lexagene Holdings's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Lexagene Holdings (Lexagene Holdings) Business Description

Traded in Other Exchanges
N/A
Address
500 Cummings Center, Suite 4550, Beverly, MA, USA, 01915
Lexagene Holdings Inc is a molecular diagnostics company that develops molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The MiQLab system delivers sensitivity, specificity, and breadth of detection and can return results in approximately two hours. The unique open-access feature is designed for custom testing so that end-users can load their own real-time PCR assays onto the instrument to target any genetic target of interest.

Lexagene Holdings (Lexagene Holdings) Headlines

From GuruFocus

LexaGene Holdings Proposes to Amend Warrants Terms

By GlobeNewswire GlobeNewswire 10-27-2022

LexaGene Announces Management Cease Trade Order

By GlobeNewswire GlobeNewswire 06-30-2022

LexaGene Holdings Proposes to Amend Warrants Terms

By Value_Insider Value_Insider 12-07-2022

LexaGene Closes Secured Convertible Note Transaction

By Value_Insider Value_Insider 11-01-2022

LexaGene Provides Update on BioPharma Sector

By Stock market mentor Stock market mentor 02-08-2023

LexaGene Files for Chapter 7 Bankruptcy

By sperokesalga sperokesalga 02-24-2023